Tariffs Blocked by Court, U.S. Steel’s Golden Shares & Neuralink’s Funding Round
Prof G Markets
00:00
Neuralink's Funding and ZBiotics Introduction
This chapter explores Neuralink's recent $600 million funding round and the potential of its groundbreaking brain-computer interface technology for individuals with spinal cord injuries. Additionally, listeners are introduced to ZBiotics, a probiotic drink aimed at mitigating the effects of alcohol consumption, along with a promotional discount offer.
Transcript
Play full episode
